* These events were reported during the postmarketing period and were observed predominantly among patients with further risk factors for QT prolongation (see section 4.4).
* Neid nähte esines turustusjärgsel perioodil ja valdavalt patsientidel, kellel oli ka teisi QT - intervalli pikenemise riskitegureid (vt lõik 4. 4).